Supplements
Vitamin B6: forms, foods, nerve toxicity, intake limits, and changing regulation
On this page
Different B6 names can appear across products
| Label name | Meaning |
|---|---|
| Pyridoxine, pyridoxal or pyridoxamine | Members of the vitamin B6 family.[1] |
| PLP or P5P | Pyridoxal-5-phosphate is a coenzyme form; a biochemical label alone does not establish clinical superiority or safety.[1] |
| Magnesium blend or multivitamin | A product marketed for something else can also contain B6.[4] |
Food sources and normal biochemical roles
Fish, poultry, chickpeas and other legumes, bananas, nuts, grains and fortified foods can contribute vitamin B6. It supports normal metabolism rather than providing an automatic energy boost above adequacy. Symptoms such as fatigue overlap many conditions; diagnosis requires more than matching symptoms to a nutrient list.[2]
Safety reports reveal a signal, not a precise incidence
TGA’s safety update describes tingling, burning or numbness with supplementary B6, including reports involving relatively low doses or several products. It does not establish a minimum dose below which no individual can be affected. Reports also lack the denominator needed to estimate the incidence among all users.[4]
Total exposure can be easy to miss when a magnesium product, a multivitamin and another blend all contain B6. An “active” form label does not replace an assessment of amounts and safety. TGA advises stopping the product and promptly seeking medical advice when these symptoms occur. This is an agency safety instruction, not a diagnosis of the symptom’s cause.[4]
A future Australian control is not a current global intake rule
On 25 November 2025, TGA announced stronger controls for higher-dose B6 products. Its implementation date is 1 June 2027. As of October 2026 that date remains in the future. Retail access categories are Australian medicine regulation, not a universal recommended daily intake or proof of safety below a sales threshold.[5]
Lowering homocysteine is not the same as preventing all cardiovascular events
HOPE-2 randomized 5,522 people with vascular disease or diabetes to a combination of folic acid, B6 and B12 or placebo over five years. Homocysteine fell without a clear reduction in the primary cardiovascular composite; stroke decreased. A favorable marker and one component outcome do not establish improvement in every endpoint, or isolate B6’s effect.[6]
A pregnancy-nausea medicine is more specific than a B6 supplement
US prescription Diclegis combines pyridoxine with doxylamine, a sedating antihistamine, in an oral delayed-release tablet. Its indication is pregnancy nausea and vomiting that has not responded to initial supportive measures; it has not been studied for hyperemesis gravidarum, a severe form of pregnancy nausea and vomiting. A B-complex supplement or an OTC sleep tablet does not reproduce that product’s formulation and instructions. The label warns about drowsiness, alcohol and driving.[7]
Evidence & uncertainty
Excess vitamin B6 can cause peripheral neuropathy. EFSA treats that association as established, while the exact dose and duration that cause harm in an individual remain uncertain. US and European upper limits differ, and Australia has announced controls that are scheduled for June 2027 rather than already implemented.[3][5]
Selected-source overview · Independent review pendingPublished questions
What are pyridoxine, pyridoxal and P5P?
Selected-source overview · Independent review pending. Read the evidence context.
They are names for compounds within the B6 family; PLP/P5P is a coenzyme form.[1]
Evidence behind this answer
- Vitamin B6: Health Professional Fact Sheet
agency nutrient or safety explanation · 2023
Selected relevant official page passages inspected · Forms, coenzyme role and older US upper limit
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Which foods can supply vitamin B6?
Selected-source overview · Independent review pending. Read the evidence context.
Fish, poultry, legumes, bananas, nuts and grain products are examples.[2]
Evidence behind this answer
- Vitamin B6 in diet
agency nutrient or safety explanation · Date not stated
Selected relevant official page passages inspected · Functions and food groups
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does water-soluble vitamin B6 mean nerve toxicity is impossible?
Selected-source overview · Independent review pending. Read the evidence context.
Excess exposure can cause neuropathy despite water solubility.[3]
Evidence behind this answer
- Scientific opinion on the tolerable upper intake level for vitamin B6
agency scientific safety assessment · 2023
Original indexed abstract and selected original result passages inspected; no independent full-text appraisal · Neuropathy, dose/time uncertainty and 12 mg adult upper limit
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can a magnesium supplement add to vitamin B6 intake?
Selected-source overview · Independent review pending. Read the evidence context.
Yes; B6 can appear in blends marketed for other ingredients.[4]
Evidence behind this answer
- Peripheral neuropathy with supplementary vitamin B6 (pyridoxine)
agency nutrient or safety explanation · 2022
Indexed selected original official safety passages inspected; direct retrieval unavailable · Symptoms, multiple products and lack of minimum threshold
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Do B6 safety reports establish an exact safe dose or incidence?
Selected-source overview · Independent review pending. Read the evidence context.
They do not supply a guaranteed safe threshold or a complete user denominator.[4]
Evidence behind this answer
- Peripheral neuropathy with supplementary vitamin B6 (pyridoxine)
agency nutrient or safety explanation · 2022
Indexed selected original official safety passages inspected; direct retrieval unavailable · Symptoms, multiple products and lack of minimum threshold
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Why are the European and older US vitamin B6 upper limits different?
Selected-source overview · Independent review pending. Read the evidence context.
Their dates, evidence assessments and uncertainty methods differ; limits are not intake goals.[1][3]
Evidence behind this answer
- Vitamin B6: Health Professional Fact Sheet
agency nutrient or safety explanation · 2023
Selected relevant official page passages inspected · Forms, coenzyme role and older US upper limit - Scientific opinion on the tolerable upper intake level for vitamin B6
agency scientific safety assessment · 2023
Original indexed abstract and selected original result passages inspected; no independent full-text appraisal · Neuropathy, dose/time uncertainty and 12 mg adult upper limit
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Were Australia’s June 2027 B6 controls already implemented in October 2026?
Selected-source overview · Independent review pending. Read the evidence context.
The announced implementation date was still in the future.[5]
Evidence behind this answer
- Stronger safety controls to be introduced for products containing vitamin B6
agency nutrient or safety explanation · 2025
Selected relevant official page passages inspected · Announced controls and 1 June 2027 implementation
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does HOPE-2 prove B6 alone prevents cardiovascular events by lowering homocysteine?
Selected-source overview · Independent review pending. Read the evidence context.
The intervention combined three vitamins and did not clearly improve the primary composite.[6]
Evidence behind this answer
- Homocysteine lowering with folic acid and B vitamins in vascular disease
randomized combination trial · 2006
Original indexed abstract and selected original result passages inspected; no independent full-text appraisal · Homocysteine, primary composite and stroke
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Is a B6 supplement interchangeable with a prescribed doxylamine–pyridoxine nausea tablet?
Selected-source overview · Independent review pending. Read the evidence context.
No. The prescription product has a specific combination, delayed-release formulation and indication. Doxylamine also adds sedation and interaction precautions; review the actual product with the pregnancy-care team.[7]
Evidence behind this answer
- DICLEGIS: doxylamine succinate and pyridoxine hydrochloride delayed-release tablets
prescription product label · 2025
Current DailyMed version 15 dated 4 December 2025 inspected; prescribing information revised June 2023. FDA archived 2022 label is an older version of the same product work, not independent evidence. · Indication; delayed-release oral formulation; somnolence, alcohol and driving warnings; clinical study
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Approval and the size of symptom relief are separate questions
The product label reports greater symptom-score improvement than placebo in its short trial. A later independent reanalysis of that same trial found a small average difference, below its prespecified three-point expected difference. Statistical significance changed with the method used for missing outcomes. This is disagreement about interpreting one trial, not a second independent confirmation or proof that nobody benefits. Neither report establishes that a generic high-dose B6 blend treats every cause of nausea.[7][8]
Different agencies can reach different excess-intake boundaries
The older US Food and Nutrition Board adult upper limit is 100 mg/day. NIH records it as a limit rather than a recommended intake. Choosing that number as a goal would confuse an excess-intake boundary with a nutritional requirement.[1]
EFSA’s 2023 adult upper limit is 12 mg/day, including pregnancy and lactation. Its neuropathy assessment accounts for uncertainty and the relationship between dose and exposure time. Different assessment dates and methods help explain the discrepancy. Neither number gives individualized clearance, and selecting the higher value does not resolve the disagreement.[3]
References
- Vitamin B6: Health Professional Fact Sheet
Agency nutrient or safety explanation
NIH Office of Dietary Supplements · Content/publication date: 2023
Accessed: 2026-10-08 UTC · Selected relevant official page passages inspected
Cited sections: Forms, coenzyme role and older US upper limitUpdated 16 June 2023; selected upper-limit passages inspected.
- Vitamin B6 in diet
Agency nutrient or safety explanation
MedlinePlus Medical Encyclopedia · Content/publication date: not stated
Accessed: 2026-10-08 UTC · Selected relevant official page passages inspected
Cited sections: Functions and food groupsNutrient literacy, not a diagnosis checklist.
- Scientific opinion on the tolerable upper intake level for vitamin B6
Agency scientific safety assessment
EFSA Panel on Nutrition, Novel Foods and Food Allergens · Content/publication date: 2023
Accessed: 2026-10-08 UTC · Original indexed abstract and selected original result passages inspected; no independent full-text appraisal
Cited sections: Neuropathy, dose/time uncertainty and 12 mg adult upper limitOriginal scientific abstract; upper bound, not a goal.
- Peripheral neuropathy with supplementary vitamin B6 (pyridoxine)
Agency nutrient or safety explanation
Therapeutic Goods Administration · Content/publication date: 2022
Accessed: 2026-10-08 UTC · Indexed selected original official safety passages inspected; direct retrieval unavailable
Cited sections: Symptoms, multiple products and lack of minimum thresholdSafety reports do not establish all-user incidence.
- Stronger safety controls to be introduced for products containing vitamin B6
Agency nutrient or safety explanation
Therapeutic Goods Administration · Content/publication date: 2025
Accessed: 2026-10-08 UTC · Selected relevant official page passages inspected
Cited sections: Announced controls and 1 June 2027 implementationFuture implementation rechecked 8 October 2026 UTC.
- Homocysteine lowering with folic acid and B vitamins in vascular disease
Randomized combination trial
Lonn E and colleagues · Content/publication date: 2006
Accessed: 2026-10-08 UTC · Original indexed abstract and selected original result passages inspected; no independent full-text appraisal
Cited sections: Homocysteine, primary composite and strokeShared with folate; linked correction not appraised.
- DICLEGIS: doxylamine succinate and pyridoxine hydrochloride delayed-release tablets
Prescription product label
Duchesnay; US prescribing information hosted by DailyMed · Content/publication date: 2025
Accessed: 2026-10-20 UTC · Current DailyMed version 15 dated 4 December 2025 inspected; prescribing information revised June 2023. FDA archived 2022 label is an older version of the same product work, not independent evidence.
Cited sections: Indication; delayed-release oral formulation; somnolence, alcohol and driving warnings; clinical study - Doxylamine-pyridoxine for nausea and vomiting of pregnancy randomized placebo controlled trial: Prespecified analyses and reanalysis
Individual trial data reanalysis
Persaud N and colleagues · Content/publication date: 2018
Accessed: 2026-10-20 UTC · Original abstract, selected analysis methods/results and limitations read. Reanalysis of DIC-301/NCT00614445, not a new randomized trial; native/Firecrawl access to the original 2010 indexed record failed. Reanalysis data extraction and interpretation have limitations.
Cited sections: Abstract; missing-outcome sensitivity analyses; comparison with prior publication; limitations and funding
Scope & review
- Population
- General product literacy; adult limits and selected vascular-disease/diabetes trial participants
- Exposure or intervention
- Food B6, blends, sustained supplement exposure and combined B vitamins
- Comparison
- Agency methods, sales categories and trial placebo
- Outcomes
- Nutrient function, peripheral neuropathy, homocysteine and cardiovascular events
- Timeframe
- Dose/duration safety context; 2023 assessment and future June 2027 controls
- Jurisdiction
- US/European nutrient limits and Australian medicine regulation
Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-08 UTC: Added a sourced explanation in a bounded ten-article batch; qualified review remains pending.
- 2026-10-20 UTC: Added bounded product/form distinctions and relevant original evidence after full-guide and neighboring-topic overlap review; previous prose retained and qualified review remains pending.
What this article still leaves open
- Individual dose-duration risk, current product composition and independent clinical review remain unresolved.
- A full current efficacy review of all B6 indications and medication contexts is outside this overview.
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.